Shionogi

Shionogi, a Japanese company founded in 1878, has extensive experience in the research, production, and sales of pharmaceuticals, and is a leader in Japan's pharmaceutical industry. It holds significant influence in areas such as anti-infectives and central nervous system diseases. Shionogi & Co., Ltd. is well-known for developing Crestor, a statin used to reduce cardiovascular diseases. In Japan, Shionogi & Co., Ltd. is recognized as a pioneer in antibiotic drugs. The company’s current product portfolio includes antivitamin preparations, analgesic antipyretics, cold medicines, sinusitis medications, digestive drugs, dermatological formulations, anti-inflammatory painkillers, cholesterol-lowering agents, and denture-related products. Shionogi’s research and development efforts are currently focused on two therapeutic areas: infectious diseases and central nervous system disorders.